DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ rallied 1.46% to $200.62 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.21% to 7,408.30 and Dow Jones Industrial Average falling 0.97% to 51,711.65.
Biogen Inc. closed 8.69% below its 52-week high of $219.72, which the company reached on June 29th.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 1.42% to $259.27, Pfizer Inc. $(PFE)$ rose 0.77% to $25.01, and AbbVie Inc. $(ABBV)$ rose 1.43% to $256.92.
Trading volume (1.0 M) remained 285,235 below its 50-day average volume of 1.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 23, 2026 16:59 ET (20:59 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.